InnoCare

InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP

Iskandar Shahril 22 February 2022 0

InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the first patient has been dosed in Phase II...

Lung Cancer Network Malaysia Confers Inaugural World Cancer Day Awards on Two Eminent Senior Professors

Teong Eu Sim 10 March 2025 0

LCNM Conducts First AI Lung Cancer Screening in Johor

Teong Eu Sim 11 December 2024 0

A Call to Action On World Lung Cancer Day – A Time of Hope, Concern & Action – Lung Cancer Network Malaysia

Teong Eu Sim 31 July 2024 0

Innovating for a Greener Future: The Rise of Plant-Based Wellness Products

Amanda Chew 10 January 2024 0

Wandong Medical Attains MDR Certification for Seven Key Product Series

Teong Eu Sim 18 December 2023 0